SK Bioscience Co Ltd (302440): Gewinn- und Verlustrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 37.250 Won (Südkorea) | 61.300 Won (Südkorea) | 31.800 Won (Südkorea) |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 32.500 Won (Südkorea) | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 78.456.553 | - | - |
Kennzahl in 1000 KRW | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
Umsatz | 651.368.342,53 | 267.545.049,15 | 369.505.555,85 | 456.725.871,19 | 929.000.929,91 | 225.610.784,86 | 183.937.702,39 | 88.173.588,38 |
Herstellungskosten | 575.444.142,95 | 236.569.373,42 | 227.262.753,95 | 217.114.929,8 | 358.717.802,8 | 130.268.716,2 | 110.901.476,92 | 48.958.069,05 |
Bruttoergebnis | 75.924.199,58 | 30.975.675,73 | 142.242.801,9 | 239.610.941,39 | 570.283.127,11 | 95.342.068,66 | 79.641.751,67 | 39.215.519,33 |
▸ Brutto-Marge | 11,66% | 11,58% | 38,5% | 52,46% | 61,39% | 42,26% | 43,3% | 44,48% |
Betriebliche Aufwendungen | 199.425.882 | 169.406.974 | 154.230.567 | 124.597.324 | 96.063.271 | 57.631.621 | 73.173.208,64 | 24.008.862 |
Operativer Gewinn/Verlust | -123.501.682,42 | -138.431.298,27 | -11.987.765,1 | 115.013.617,39 | 474.219.856,11 | 37.710.447,66 | 6.468.543,03 | 15.206.657,33 |
▸ Operative Marge | -18,96% | -51,74% | -3,24% | 25,18% | 51,05% | 16,71% | 3,52% | 17,25% |
Zinsen (Netto) | 6.274.522 | 3.293.170 | 12.157.215 | 2.393.504 | -1.910.409 | -3.681.102 | -3.818.135,87 | -2.419.772 |
▸ Zinsausgaben | 9.399.218 | 3.684.910 | 1.398.139 | 2.460.940 | 3.426.927 | 4.150.694 | 3.977.356,87 | 2.420.695 |
▸ Zinseinnahmen | 15.673.740 | 6.978.080 | 13.555.354 | 4.854.444 | 1.516.518 | 469.592 | 159.221 | 923 |
Andere Ausgaben | -31.367.043,55 | -46.031.299,92 | -7.157.777,48 | -24.326.061,06 | 1.181.266,58 | -3.263.907,12 | -15.834.865,66 | 11.922.895,12 |
Gewinn vor Steuern | -85.860.116,87 | -89.106.828,35 | 7.327.227,38 | 141.733.182,45 | 471.128.180,53 | 37.293.252,78 | 18.485.272,82 | 863.990,21 |
Steueraufwand | - | - | - | - | 115.988.903,69 | 4.403.540,83 | - | - |
Minderheitenanteil | -28.435.634,89 | -35.225.629,45 | -14.990.491,85 | 19.281.232,52 | -1,93 | -0,52 | 3.807.868,05 | 443.145,68 |
Nettogewinn/-verlust | -57.424.481,98 | -53.881.198,9 | 22.317.719,23 | 122.451.949,93 | 355.139.278,77 | 32.889.712,47 | 14.677.404,77 | 420.844,53 |
▸ Netto-Marge | -8,82% | -20,14% | 6,04% | 26,81% | 38,23% | 14,58% | 7,98% | 0,48% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.